DOD Biotech Public Company Limited

SET:DOD Rapport sur les actions

Capitalisation boursière : ฿1.1b

DOD Biotech Bilan de santé

Santé financière contrôle des critères 5/6

DOD Biotech has a total shareholder equity of THB874.9M and total debt of THB87.1M, which brings its debt-to-equity ratio to 10%. Its total assets and total liabilities are THB1.2B and THB328.8M respectively.

Informations clés

10.0%

Ratio d'endettement

฿87.08m

Dette

Ratio de couverture des intérêtsn/a
Argent liquide฿75.71m
Fonds propres฿874.92m
Total du passif฿328.82m
Total des actifs฿1.20b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Analyse de la situation financière

Passif à court terme: DOD's short term assets (THB471.9M) exceed its short term liabilities (THB242.1M).

Passif à long terme: DOD's short term assets (THB471.9M) exceed its long term liabilities (THB86.7M).


Historique et analyse du ratio d'endettement

Niveau d'endettement: DOD's net debt to equity ratio (1.3%) is considered satisfactory.

Réduire la dette: DOD's debt to equity ratio has reduced from 10.4% to 10% over the past 5 years.

Couverture de la dette: DOD's debt is well covered by operating cash flow (66.1%).

Couverture des intérêts: Insufficient data to determine if DOD's interest payments on its debt are well covered by EBIT.


Bilan


Découvrir des entreprises saines